Moore Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-90,000
Closed -$23.3M 457
2023
Q4
$23.3M Buy
90,000
+30,000
+50% +$7.37M 0.56% 43
2023
Q3
$15.4M Buy
+60,000
New +$16M 0.42% 68
2023
Q2
Sell
-1,500
Closed -$417K 530
2023
Q1
$417K Buy
+1,500
New +$415K 0.01% 328
2022
Q4
Sell
-17,995
Closed -$4.8M 561
2022
Q3
$4.8M Sell
17,995
-10,684
-37% -$2.27M 0.13% 202
2022
Q2
$5.85M Buy
+28,679
New +$5.86M 0.18% 147
2021
Q4
Sell
-20,206
Closed -$5.72M 750
2021
Q3
$5.72M Sell
20,206
-58,952
-74% -$19.3M 0.12% 225
2021
Q2
$27.4M Buy
+79,158
New +$24M 0.5% 56
2020
Q1
Sell
-9,924
Closed -$2.94M 173
2019
Q4
$2.94M Buy
+9,924
New +$2.75M 0.11% 174
2019
Q1
Sell
-33,792
Closed -$10.2M 297
2018
Q4
$10.2M Buy
+33,792
New +$10.8M 0.53% 50
2014
Q3
Sell
-32,500
Closed -$10.2M 408
2014
Q2
$10.2M Buy
+32,500
New +$9.78M 0.36% 103
2013
Q4
Sell
-10,000
Closed -$2.41M 375
2013
Q3
$2.41M Buy
10,000
+5,000
+100% +$1.12M 0.1% 229
2013
Q2
$1.08M Buy
+5,000
New +$1.07M 0.05% 244

Other funds holding BIIB